Tenders Are Invited For Various Medicinal Products – Supply Of Oncological Drugs In The Drug And Chemotherapy Program For The Needs Of Cozl. (Proceeding Number: Cozl/Dzp/Aw/3411/Pn-190/25)

Various Medicinal Products – Supply Of Oncological Drugs In The Drug And Chemotherapy Program For The Needs Of Cozl. (Proceeding Number: Cozl/Dzp/Aw/3411/Pn-190/25). Part 1 – Vandetanib,Part 2 – Romosozumab,Part 3 – Carboplatin,Part 4 – Methotrexate,Part 5 – Siltuximab,Part 6 – Acidum Zoledronicum,Part 7 – Desatinib,Part 8 – Filgrastin,Part 9 – Melphalanum,Part 10 – Pegfilgrastim,Part 11 – Tacrolimus,Part 12 – Chlorambucil,Part 13 – Temsirolimusum,Part 14 – Crizotinibum,Part 15 – Melphalan,Part 16 – Trabectidine,,Part 18 – Avelumab,Part 19 – Ponatinibum,Part 20 – Mosunetuzumab,Part 21 – Isatuximab,Part 22 – Tretinoin,Part 23 – Ravulizumab,Part 24 – Nivolumab + Relatlimab,Part 25 – Mitoxantrone,Part 26 - Epirubicin,Part 27 – Bicalutamide I,Part 28 – Cabazytaxel,Part 29 – Liposomal Doxorubicin,,Part 31 – Mitomycin,Part 32 – Pertuzumab,Part 33 – Rasburicasum,Part 34 – Obinutuzumab,Part 35 – Trastuzumab Emtansine,Part 36 – Venetoclaxum,Part 37 – Ibrutinib,Part 38 – Cyclophosphamide,Part 39 – Mesnum,Part 40 – Ifosfamide,Part 41 – Panitumumab,Part 42 – Pegaspargase,Part 43 – Niraparib,Part 44 - Capecitabine,Part 45 - Fulvestrantum,Part 46 – Everolimus,Part 47 – Paclitaxelum Albuminatum,Part 48 – Pemetrexet,Part 49 – Oxaliplatin,Part 50 – Rybocyclib,Part 51 – Trametinib,Part 52 – Octreotide,Part 53 – Nilotinib,Part 54 – Sunitinib,Part 55 – Vinorelbina,Part 56 – Bleomycin,Part 57 – Dacarbazine,Part 58 – Acidum Levofolinicum,Part 59 – Fluorouracil,Part 60 – Inotuzumabum Ozogamicini,Part 61 – Bicalutamide Ii